This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Canine TGF Beta-Activated Kinase 1 and MAP3K7-Binding Protein 1 (TAB1) Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for canine TGF beta-activated kinase 1 and MAP3K7-binding protein 1. It is purified by affinity chromatography. It can be applied to WB assay of canine TGF beta-activated kinase 1 and MAP3K7-binding protein 1.
Specifications
Target Information
Canine TGF Beta-Activated Kinase 1 (TAK1, MAP3K7) and its binding protein 1 (TAB1, MAP3K7IP1) are key components in intracellular signaling pathways. TAK1 is a MAP kinase kinase kinase involved in mediating signaling cascades triggered by TGF-β, IL-1, and TNF-α, playing crucial roles in inflammation, cell survival, and apoptosis. TAB1 is a regulator of TAK1, facilitating its activation and mediating downstream signaling. In canine research, these proteins are essential for understanding cellular responses to environmental changes and cytokine signaling.
Shipping and Storage
This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.